Pfizer says its ultra-low dose vaccine isn't enough for kids aged 2-5 — setting up a booster scenario that could delay toddlers' shots until mid-2022

Pfizer says its ultra-low dose vaccine isn't enough for kids aged 2-5 — setting up a booster scenario that could delay toddlers' shots until mid-2022

Business Insider

Published

A low dose of Pfizer's vaccine worked well in babies, but not so well in 2- to 5-year-olds. It means toddlers may not get shots until mid-2022.

Full Article